帕金森病中的区域白质过强度体积和与运动标志的关联
Haoting Wu1, Hui Hong1, Chenqing Wu1
1Department of Radiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
Annals of clinical and translational neurology
|June 24, 2023
概括
帕金森病 (PD) 患者在部区域显示白质强度 (WMH) 增加. 这种尾WMH体积与运动症状有关,但不能预测它们的长期进展.
科学领域:
- 神经成像是一种神经成像.
- 神经学 神经学
- 神经退行发生神经退行.
背景情况:
- 白质超强度 (WMH) 在衰老和神经退行性疾病中很常见.
- 了解WMH在帕金森病 (PD) 中的特定区域影响对于疾病的表征至关重要.
研究的目的:
- 调查区域白质强度过高 (WMH) 量与帕金森病 (PD) 之间的关联.
- 评估WMH对PD患者运动征兆的横截面和纵向影响.
主要方法:
- 在50名PD患者和47名对照人群之间,比较了特定大脑区域的WMH体积.
- 使用线性回归进行横截面分析,并使用线性混合效应模型进行两年长度分析.
- 评估了WMH体积和运动症状之间的相关性,包括震,步态和姿势.
主要成果:
- 与对照人群相比,PD患者在部区域的WMH体积显著增加.
- 尾WMH体积显示在PD中与运动障碍 (发,步态,姿势) 有显著的截面相关性.
- 稳定的WMH体积和运动征兆的进展之间没有发现显著的纵向关联.
结论:
- 帕金森病与尾白质过强度增加有关.
- 尾WMH体积与单个时间点的运动症状严重程度相关.
- 在2年的随访期间,WMH体积并不能预测PD中运动征兆的进展.
相关概念视频
Parkinson's Disease: Overview
607
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
607
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303


